James Scowcroft, MD
Pain Medicine · Lees Summit, MONPI 1285615450
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,635 of the $7,323 with a category attached, or 77.0%. 27 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 43.9% of the total. Reporting peaked in 2023 at $3,548 and has fallen 86.7% since, to $473 in 2025.
Across 157 payments — averaging $46.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Nevro Corp.$2K
- Medtronic$485
- Abbott$363
- Boston Scientific$180
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$176
- plus $1K from 21 others
Across 296 payments — averaging $6193.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$1.3M
- Boston Scientific$445K
- Saluda Medical Americas, Inc.$59K
What the payments were for
- Travel & lodging$1,68723%
- Food & beverage$5,63577%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 12 | $3,211 |
| Nevro Corp. | 44 | $1,759 |
| Medtronic(2 entities) | 17 | $485 |
| Abbott | 10 | $363 |
| Boston Scientific | 8 | $180 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $176 |
| MML US, Inc. | 1 | $167 |
| AbbVie(2 entities) | 15 | $163 |
| Globus Medical | 2 | $112 |
| Tersera Therapeutics LLC | 5 | $111 |
| Collegium Pharmaceutical, Inc. | 5 | $95 |
| GRT US Holding, Inc. | 5 | $77 |
| SPR Therapeutics, Inc | 3 | $62 |
| Fidia Pharma USA Inc. | 2 | $59 |
| Vertex | 2 | $45 |
| Nalu Medical, Inc. | 1 | $36 |
| Convatec Inc. | 2 | $35 |
| Pfizer | 2 | $32 |
| Daiichi Sankyo Inc. | 2 | $26 |
| Si-bone, Inc. | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| International Rehabilitative Sciences, Inc | 1 | $13 |
| Electronic Waveform Lab, Inc. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Vertiflex, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke SCS$2,889
- Senza Spinal Cord Stimulation System$468
- Senza$284
- ReActiv8$167
- Neuromodulation Dspsbls and Accs$165
- INTELLIS$158
- Evoke$112
How this compares
$7,323 in reported general payments places this provider in the 75th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 126 | $14,027 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 380 | $10,398 |
| OxycontinOxycodone Hcl | 12 | $9,795 |
| MovantikNaloxegol Oxalate | 23 | $9,241 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 282 | $9,177 |
| Pregabalin | 302 | $5,676 |
| Gabapentin | 289 | $5,546 |
| Morphine Sulfate ErMorphine Sulfate | 85 | $3,753 |
| Lidocaine | 38 | $3,445 |
| Tizanidine Hcl | 113 | $3,182 |
| Oxycodone Hcl | 138 | $2,590 |
| Baclofen | 90 | $1,472 |
| Naproxen | 136 | $1,011 |
| Duloxetine Hcl | 70 | $974 |
| Methylprednisolone | 82 | $627 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lees Summit
- Nicholas DonohueLees Summit$15K
- Morgan GonderLees Summit$6K
- Joel AckermanLees Summit$5K
- Mark ChaplickLees Summit$4K
- Jarron TilghmanLees Summit$4K
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.